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1. Introduction
Cathepsin C (dipeptidyl peptidase I, EC 3.4.14.1) is a 
lysosomal cysteine protease belonging to the papain 
superfamily (Izumya and Fruton, 1956). Besides its role 
in lysosomal protein degradation (Coffey and de Duve, 
1968), CatC is a key enzyme in the activation of many 
serine proteinases that are capable of degrading various 
extracellular matrix components and can lead to tissue 
damage and chronic inflammation such as chronic 
obstructive pulmonary disease and asthma (Wolters et 
al., 2000; Adkinson et al., 2002; Kim and Nadel, 2004). 
At the same time, related studies have demonstrated that 
inhibitors of CatC could potentially be useful therapeutics 
for the treatment of such diseases (Methot et al., 2007, 
2008). Therefore, production of recombinant human CatC 
protein in an effort to develop inhibitors of this enzyme is 
highly appreciated. In addition to this importance, due to 
its unique proteolytic specificity in sequential removal of 
dipeptides from the amino terminus of protein substrates, 
attention has also been drawn to the industrial applications 
of CatC as a processing exopeptidase to use in amino acid 
sequencing of proteins and removal of fusion peptides 
from the N-termini of recombinant proteins (Lauritzen et 
al., 1998; Pedersen et al., 1999).
The methylotrophic yeast Pichia pastoris is a very 
successful microbial heterologous protein expression 
host that can be grown to high cell densities in simple 
and cheap medium and is capable of secreting large 
amounts of correctly folded eukaryotic recombinant 
proteins in simple media (Cereghino and Cregg, 2000). 
Contrary to bacterial expression systems, P. pastoris allows 
posttranslational modifications such as disulfide bond 
formation, glycosylation similar to eukaryotic cells, and 
proteolytic maturation (Cregg et al., 1993). One of the 
most important benefits of this strain as an expression 
host is that it does not have papain-like cysteine proteases 
in its genome. The absence of protease homologs in the 
host genome majorly simplifies the purification of the 
recombinant protein (Linnevers et al., 1997).
To date, a number of studies have been reported 
on recombinant expression of human CatC that were 
performed in insect and mammalian cell systems (Dahl 
et al., 2001; Yang et al., 2011). However, these systems are 
high-cost methods that require complex and expensive 
media and involve cumbersome work procedures. In this 
study, the expression pattern of the human CatC gene in 
the yeast P. pastoris was studied for simple and effective 
protein production. Its cDNA synthesis, recombinant 
expression, extracellular secretion, proteolytic maturation, 
and enzymatic activity are reported. It was found that the 
yeast P. pastoris expression system is capable of expressing 
the proform of the enzyme efficiently, which can be further 
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maturated by cysteine endoprotease papain in vitro. To my 
knowledge, this is the first study reporting human CatC 
recombinant expression in P. pastoris.
2. Material and methods
2.1. Materials 
The Pichia pastoris expression kit and TRIzol reagent were 
purchased from Invitrogen. Human peripheral blood 
mononuclear cells (PBMCs) were provided by Lonza. E. 
coli DH5α was used for construction and propagation of 
all vectors. The pGEM-T Easy vector was from Promega. 
DNA restriction enzymes and RT-PCR Kit were from New 
England Biolabs. Interleukin-2 (IL-2) was from Santa Cruz 
Biotechnology. Papain from papaya latex and Gly-Phe-
p-nitroanilide were purchased from Sigma. RPMI-1640 
growth medium, 10% fetal bovine serum, streptomycin, 
and penicillin were from GIBCO Life Technologies. All 
other chemicals and reagents were of the highest purity.
2.2. CatC cDNA synthesis and pGEM-T-CatC 
construction
PBMCs were cultured in RPMI-1640 growth medium 
supplemented with 10% fetal bovine serum, 100 U/mL 
penicillin, and 100 pg/mL streptomycin and stimulated 
with IL-2 (1000 U / 2 × 106 cells/mL) to increase CatC 
mRNA levels for 48 h at 37 °C under 5% CO2 (Rao et al., 
1997). After incubation, total RNA of the stimulated cells 
was isolated with TRIzol reagent. Briefly, the stimulated 
cells were harvested and washed twice with phosphate-
buffered saline. The cells were lysed with 1 mL of TRIzol 
by pipetting and incubated at room temperature for 5 min 
to dissociate nucleoprotein complexes. Chloroform (0.2 
mL) was then added to the lysate and mixed by stirring for 
2 min. After centrifugation (at 4 °C and 12,000 × g for 15 
min), the mixture separated into three phases, consisting 
of a lower organic phase, an interphase, and an upper 
aqueous phase. The aqueous phase was transferred to a 
fresh centrifuge tube in the presence of 0.5 mL of isopropyl 
alcohol and incubated at room temperature for 10 min. 
Finally, total RNA was precipitated via centrifugation (at 4 
°C and 12,000 × g for 10 min), washed twice with 1 mL of 
75% ethanol, and dissolved in 50 µL of RNase-free water. 
The reverse transcription of total RNA into cDNA 
was performed using the first-strand cDNA synthesis 
kit according to the manufacturer’s instructions. The 
CatC-encoding region was amplified from the cDNA 
pool by PCR using the following primers: forward 
primer 5’-GGG CGG CCG CAT GGG TGC TGG GCC 
CTC CT and reverse primer 5’-GGG CGG CCG CCC 
CTA CAA TTT AGG AAT TGG TGT (NotI recognition 
sequence is underlined). Primers contained NotI sites for 
cloning into the P. pastoris expression vector pPICZαA. 
The PCR amplification reaction consisted of an initial 
denaturation step at 94 °C for 5 min, followed by 35 cycles 
of denaturation at 94 °C for 30 s, annealing at 65 °C for 40 
s, and extension at 72 °C for 100 s; a final extension step 
of 10 min at 72 °C was added at the end of this reaction. 
The PCR product was then analyzed on an agarose gel and 
directly subcloned into the pGEM-T Easy cloning vector 
using the TA cloning system. The nucleotide sequence 
of the insert in the resulting pGEM-T-CatC vector was 
confirmed by DNA sequencing using the T7 and SP6 
promoter sequencing primers. 
2.3. Construction and transformation of pPICZαA-CatC 
expression vector
The pGEM-T-CatC cloning vector was transformed 
into E. coli DH5α competent cells using the classic heat 
shock method and grown overnight at 37 °C on LB plates 
(1% tryptone, 0.5% yeast extract, 0.5% NaCl, and 1.5% 
agar) containing 50 µg/mL ampicillin. After 24 h, white 
colonies were selected and the presence of the insert was 
determined by employing colony PCR. The transformed 
colonies were then grown overnight at 37 °C and 200 
rpm in LB medium (1% tryptone, 0.5% yeast extract, 
0.5% NaCl) containing 50 µg/mL ampicillin and plasmid 
purification was performed. In the resultant plasmid, 
pGEM-T-CatC, the 1.4-kb NotI fragment encoding CatC 
was excised from the vector, ligated into the NotI site at 
the multicloning site of the pPICZαA expression vector, 
and transformed into DH5α cells, and subsequently the 
transformed colonies were grown overnight at 37 °C on LB 
plates containing 25 µg/mL Zeocin. After 24 h, the Zeocin-
resistant transformants were inoculated into LB medium 
containing 25 µg/mL Zeocin and grown overnight at 
37 °C and 200 rpm. Upon plasmid purification from an 
overnight bacterial culture, the presence of the insert was 
determined by PCR amplification using CatC-specific 
primers. The expression vector bearing the CatC cDNA, 
pPICZαA-CatC, was then linearized with SacI to integrate 
the expression cassette into the genome of P. pastoris 
and electroporated into P. pastoris X-33 host cells using 
standard procedures (Invitrogen). After transformation, 
aliquots of 100 µL were plated on YPD plates (1% yeast 
extract, 2% peptone, 2% glucose, and 2% agar) containing 
100 µg/mL Zeocin and incubated for 2 days at 30 °C. 
The presence of the expression cassette in the genome of 
Zeocin-resistant clones was confirmed by colony PCR 
using CatC-specific primers.
2.4. Expression and analysis of CatC in Pichia pastoris
The clones proven to contain recombinant human CatC 
integrated into the P. pastoris genome were selected and 
examined for productivity. Briefly, a single recombinant 
clone was picked and grown in 25 mL of BMGY medium 
(1% yeast extract, 2% peptone, 100 mM potassium 
phosphate buffer, pH 6.0, 1.34% yeast nitrogen base, 4 
× 10–5% biotin, and 1% glycerol supplemented with 100 
µg/mL Zeocin) at 30 °C and 250 rpm until an OD600 of 
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2.0–6.0 was reached. The cells of this preculture were then 
collected by centrifugation (at room temperature and 4000 
× g for 5 min) and used to inoculate 100 mL of BMMY 
medium (same as BMGY but using 0.5% methanol instead 
of glycerol) in a 1-L baffled flask to an OD600 of about 1.0. 
Induction of the recombinant protein expression was 
performed and maintained by daily feeding of the culture 
with methanol (a final concentration of 0.5%). After 72 h, 
the cells were harvested by centrifugation (at 4 °C and 4000 
× g for 10 min) and the clear supernatant was concentrated 
(20-fold) with ultrafiltration and then recovered as a crude 
enzyme preparation. The resulting supernatant sample was 
analyzed by SDS-PAGE using polyacrylamide gel (12.5%) 
with a stacking gel (5%) under reducing conditions.
2.5. Proteolytic maturation and activity studies of CatC
Since P. pastoris expression systems lack papain-like 
cysteine proteases in their genome, papain was used to 
activate recombinant CatC to mimic the in vivo proteolytic 
process. First, the concentrated P. pastoris culture 
supernatant containing proCatC was loaded on a HiTrap 
SP column and eluted with a 0–1 M NaCl gradient in 20 
mM citric acid, pH 6.5, containing 1 mM EDTA and 5 mM 
dithiothreitol to further purify the preparation. The eluted 
proCatC between 0.2 and 0.3 M NaCl was then treated 
with papain (20 µg/mL) to digest the CatC precursor 
in a shaker for 4 h at 37 °C and 200 rpm. Residual CatC 
activity was monitored in the aliquots withdrawn from 
the preincubation mixture at predetermined time points. 
The activities were measured in an assay buffer containing 
20 mM citric acid, pH 4.5, 150 mM NaCl, 1 mM EDTA, 
and 5 mM dithiothreitol using the chromogenic substrate 
Gly-Phe-pNA (0.1%), which gives yellow-colored 
p-nitroaniline (p-NA) upon hydrolysis, and the change 
in absorbance at 405 nm (37 °C) was monitored. For 
calibration, p-NA solutions of 1.0 to 50 mM were used. At 
the end of incubation, proteolytic activation of CatC was 
analyzed by SDS-PAGE. After activity assays, inhibition 
studies with iodoacetamide were performed in the assay 
buffer with increasing concentrations (0.01/0.1/1.0 mM) to 
examine the inhibition of the produced enzyme. One unit 
of CatC activity was expressed as the amount of enzyme 
required to convert 1 µmol of substrate per minute under 
optimum reaction conditions. Each result represents the 
mean of three independent experiments performed in 
triplicate on the same sample.
3. Results
3.1. Synthesis of CatC cDNA and construction and 
transformation of pPICZαA-CatC vector
A full-length CatC cDNA, corresponding to amino acids 
12–475, was synthesized from interleukin-2 stimulated 
PBMCs. Since human CatC is present at low levels in 
unstimulated lymphocytes, the transcription of the CatC 
gene was upregulated by IL-2 before total RNA isolation 
from PBMCs. After induction of human CatC mRNA for 
48 h, total RNA of the stimulated cells was isolated and 
reverse transcribed into cDNA. The full-length CatC 
cDNA was then successfully amplified from the cDNA 
pool using CatC primers and a 1.4-kb fragment encoding 
CatC was produced (Figure 1).
After gel purification, the concentrated full-length 
CatC was cloned into the pGEM-T Easy cloning vector 
and transformed into E. coli DH5α cells. The nucleotide 
sequence of the insert in the selected transformed clones 
was then determined to confirm that changes had not 
occurred in the cDNA sequence using the T7 and SP6 
promoter primers on a commercial basis. 
After confirming the nucleotide sequence of the insert, 
NotI digestion was performed to liberate the 1.4-kb CatC 
cDNA from the pGEM-T-CatC vector and it was ligated 
into the NotI site at the multicloning site of the pPICZαA 
expression vector to construct the pPICZαA-CatC vector 
(Figure 2).
The pPICZαA-CatC expression vector was then 
linearized with SacI to integrate the expression cassette 
into the P. pastoris genome and transformed into the strain 
X-33, yielding the new strain P. pastoris X-33 pPICZαA-
CatC-WT. Genomic integration of the expression cassette 
encoding CatC was confirmed by colony PCR using CatC 
primers as shown in Figure 3.
3.2. Expression and activation of recombinant human 
CatC
To generate a functional protease for in vitro studies, 
recombinant human cathepsin C production was 
investigated in the yeast P. pastoris expression system. 
Since this strain does not contain papain-like cysteine 
proteases in its genome (Linnevers et al., 1997) and the 
proenzyme is not capable of autoactivation (Dahl et al., 
2001), the analysis of the culture supernatant revealed that 
recombinant human CatC was secreted as a proenzyme 
with a mass of approximately 58 kDa, which is consistent 
with the mass of proCatC previously reported (Dahl et al., 
2001) (Figure 4).
It was previously demonstrated that maturation of 
proCatC with papain results in a 2000-fold increase 
in activity (Lauritzen et al., 1998). On the basis of this 
observation, proCatC was treated with papain to mimic 
the in vivo proteolytic process and to exert its proteinase 
activity. As shown in Figure 5, the inactive proCatC was 
gradually converted into its active form in the medium. 
SDS-PAGE analysis of the sample showed that the 58-
kDa proCatC band disappeared after the incubation and 
new protein bands appeared with molecular masses of 25, 
18, 12, and 7 kDa, which are in good agreement with the 
molecular weights obtained in other studies. It has been 
reported that mature CatC isolated from mammalian 
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tissues was cleaved into a heavy chain of 25 kDa (19 kDa 
without glycosylation) and a light chain of 7.8 kDa, and 
the molecular weights of 18 and 12 kDa correspond to 
the excised propeptide (Dolenc et al., 1995; Cigic et al., 
1998). The two bands at 37 and 28 kDa, corresponding to 
the intermediate polypeptides, resulted from incomplete 
proteolytic maturation (Demirov et al., 1999), whereas the 
21-kDa band corresponds to papain.
Both autocatalytic and papain-induced activation 
levels of the wild-type proenzyme into active CatC were 
monitored. According to the results, autoactivation was 
very weak and showed no enzymatic activity, whereas 
incubation of the precursor with papain resulted in 
activation and processed the proenzyme into its active 
mature form. After 4 h at 37 °C incubation, the activation 
level of CatC reached 9.6 U/mg, corresponding to 
approximately 23 mg of mature recombinant CatC per 
liter of culture (Figure 6). This enzymatic activity toward 
the studied synthetic substrate was high and comparable 
with that of the results reported previously (Dahl et al., 
2001; Yang et al., 2011).
Lastly, to determine whether the produced enzyme 
could be inhibited, an inhibition assay was performed after 
maturation of CatC. Since CatC does not possess a specific 
inhibitor, iodoacetamide was used as a general cysteine 
protease inhibitor. Iodoacetamide inhibited CatC by 6.4%, 
22.1%, and 52.7% for 0.01, 0.1, and 1.0 mM concentrations, 
respectively, confirming that the produced active enzyme 
could be used for the development of specific inhibitors.   
Figure 1. Amplification of 1.4-kb CatC fragment from the cDNA 
pool using CatC primers.
Figure 2. Map of the expression vector pPICZαA-CatC. 5’AOX1: 
Alcohol oxidase 1 promoter region allows methanol-inducible 
expression in P. pastoris; CatC: sequence encoding human 
cathepsin C; AOX1 TT: transcription termination region; PTEF1: 
TEF1 promotor; PEM7: EM7 promotor; Zeocin: Zeocin resistance 
gene; CYC1 TT: transcription termination region processing 
of resistance gene mRNA and pUC-ori: origin of replication 
functional in E. coli.
Figure 3. Confirmation of genomic integration of expression 
cassette encoding CatC by PCR using CatC primers (1–4: PCR 
using genomic DNA of selected clones).
DAĞLIOĞLU / Turk J Biol
750
4. Discussion
In this work, the methylotrophic yeast P. pastoris expression 
system was tested for its ability to express human cysteine 
proteinase CatC. Successful recombinant production of 
human CatC is reported. Several expression systems were 
studied in recent years for the recombinant production 
of human CatC. In those previous reports, recombinant 
production of CatC was described in mammalian and 
baculovirus-infected insect cell systems (Dahl et al., 2001; 
Yang et al., 2011). However, mammalian systems are 
complicated, expensive to handle, and mostly inappropriate 
for high-level expression of a functional enzyme. Although 
baculovirus-infected insect cells are simpler systems as 
compared to mammalian systems, their complicated 
cultivation and expensive media makes large-scale 
production difficult (Demain and Vaishnav, 2009). In contrast 
to these systems, the yeast P. pastoris is a much cheaper 
alternative that provides ease of handling in transformation, 
cultivation, and upscaling of the strain (Cregg et al., 1993). 
The benefits of using this strain are: 1) cells grow easily to 
high cell densities, 2) the strain allows posttranslational 
modifications similar to eukaryotic cells, 3) gene expression 
is strictly controlled by carbon sources and induced by 
methanol, 4) this protease-deficient strain can increase 
the yield of secreted recombinant protein by eliminating 
undesirable proteolysis risk occurring after secretion of 
the protein, and 5) the strain secretes few native proteins 
into the culture medium, thereby allowing purification of 
the secreted recombinant protein in a single step from the 
culture medium (Linnevers et al., 1997; Cereghino and 
Cregg, 2000). To date, a number of active human cathepsin 
proteinases, including cathepsin K (Linnevers et al., 1997), F 
(Wang et al., 1998), and V (Brömme et al., 1999), have been 
expressed in P. pastoris, whereas there is no information 
available on human cathepsin C so far. 
CatC is an unusual cysteine protease in that it has a 
very long pro-peptide of ~200 amino acids at the extension 
of the N-terminus. The residual propart of this proregion 
remains attached in the mature enzyme, which makes CatC 
unique, whereas the internal activation peptide is excised 
during maturation (Cigic and Pain, 1999). In this process, 
the structure of CatC undergoes a series of transformations 
from the proenzyme to the mature enzyme (Muno et al., 
1993). ProCatC is not capable of autoactivation, whereas 
many cathepsins of this family such as cathepsins B, K, 
L, S, F, and V possess this feature (Dahl et al., 2001). The 
endoproteases that excise the CatC proregion and cleave 
the catalytic region into heavy and light chains in vivo 
Figure 4. SDS-PAGE analysis of the culture supernatant.
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Figure 5. SDS-PAGE analysis of proCatC maturation by papain. Purified proCatC 
was incubated with papain (20 µg/mL) at pH 6.5 and 37 °C for 4 h. The reaction 
was stopped by the addition of SDS-PAGE sample buffer.
Figure 6. Time-dependent activation of CatC during maturation of proCatC 
at pH 6.5, 37 °C with papain (●) or at pH 4.5, 37 °C without (■) (to examine 
autoactivation). Aliquots were withdrawn from the preincubation mixture at the 
indicated time points, and the activity was monitored in assay buffer containing 
20 mM citric acid, pH 4.5, 150 mM NaCl, 1 mM EDTA, and 5 mM dithiothreitol 
with 0.1% Gly-Phe-pNA.
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are unknown, but it has been shown that proCatC can 
be efficiently activated with papain, and cathepsin L and 
S (Lauritzen et al., 1998; Dahl et al., 2001). Therefore, 
proCatC was treated with papain to mimic the in vivo 
proteolytic process and activate the proenzyme into its 
mature form, which led to active recombinant human CatC 
being successfully obtained. Mature CatC reached high 
specific activity (U/mg) in 4 h towards synthetic substrate 
Gly-Phe-pNA and was considerably inhibited after in vitro 
incubation with the general cysteine protease inhibitor 
iodoacetamide, which corroborates the use of recombinant 
CatC in the development of specific inhibitors against CatC-
related diseases. Furthermore, recombinant CatC could be 
of potential value for industrial applications as a processing 
exopeptidase to use in amino acid sequencing of proteins 
and removal of fusion peptides from the amino termini of 
recombinant proteins.
In conclusion, this study demonstrated for the first 
time that the yeast P. pastoris is a functional heterologous 
protein expression host for the production of recombinant 
human CatC and may serve as a faster and cheaper 
alternative to other expression systems, which might 
promote future studies on the development of specific 
CatC inhibitors and the use of CatC as a processing 
enzyme in the pharmaceutical and biotechnology 
industries.
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